Appello Pharmaceuticals is a neurology therapeutics company focused on identifying and developing innovative early-stage drugs for patients living with disorders of the central nervous system.

Based in Nashville, Tennessee, our team has a proven ability to translate ground-breaking academic discoveries into drug development programs that can quickly advance into and through clinical development. We are fortunate to have a strong collaborative relationship with Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (WCNDD), where our drug development programs originated.